223 related articles for article (PubMed ID: 17403719)
1. Increase in serum adiponectin concentration in patients with heart failure and cachexia: relationship with leptin, other cytokines, and B-type natriuretic peptide.
McEntegart MB; Awede B; Petrie MC; Sattar N; Dunn FG; MacFarlane NG; McMurray JJ
Eur Heart J; 2007 Apr; 28(7):829-35. PubMed ID: 17403719
[TBL] [Abstract][Full Text] [Related]
2. Adiponectin in outpatients with coronary artery disease: independent predictors and relationship with heart failure.
Baldasseroni S; Mannucci E; Orso F; Di Serio C; Pratesi A; Bartoli N; Marella GA; Colombi C; Foschini A; Valoti P; Mossello E; Fumagalli S; Marchionni N; Tarantini F
Nutr Metab Cardiovasc Dis; 2012 Mar; 22(3):292-9. PubMed ID: 22032915
[TBL] [Abstract][Full Text] [Related]
3. Lipolytic effects of B-type natriuretic peptide 1-32 in adipose tissue of heart failure patients compared with healthy controls.
Polak J; Kotrc M; Wedellova Z; Jabor A; Malek I; Kautzner J; Kazdova L; Melenovsky V
J Am Coll Cardiol; 2011 Sep; 58(11):1119-25. PubMed ID: 21884948
[TBL] [Abstract][Full Text] [Related]
4. Relationship between thoracic fluid content and natriuretic peptide type B in patients with systolic heart failure.
Balak W; Sinkiewicz W; Gilewski W; Karasek D; Błazejewski J; Dudziak J
Kardiol Pol; 2009 Nov; 67(11):1220-5. PubMed ID: 20024849
[TBL] [Abstract][Full Text] [Related]
5. Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease.
Neuhold S; Huelsmann M; Strunk G; Stoiser B; Struck J; Morgenthaler NG; Bergmann A; Moertl D; Berger R; Pacher R
J Am Coll Cardiol; 2008 Jul; 52(4):266-72. PubMed ID: 18634981
[TBL] [Abstract][Full Text] [Related]
6. High sensitive C-reactive protein, adiponectin, and urine albumin excretion rate in Chinese coronary artery disease patients with different glucose tolerance status.
Gui MH; Hong J; Lü AK; Chen Y; Shen WF; Li XY; Ning G
Chin Med J (Engl); 2008 Dec; 121(24):2509-16. PubMed ID: 19187587
[TBL] [Abstract][Full Text] [Related]
7. Plasma adiponectin concentration in healthy pre- and postmenopausal women: relationship with body composition, bone mineral, and metabolic variables.
Jürimäe J; Jürimäe T
Am J Physiol Endocrinol Metab; 2007 Jul; 293(1):E42-7. PubMed ID: 17341545
[TBL] [Abstract][Full Text] [Related]
8. Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure.
Fonarow GC; Peacock WF; Phillips CO; Givertz MM; Lopatin M;
J Am Coll Cardiol; 2007 May; 49(19):1943-50. PubMed ID: 17498579
[TBL] [Abstract][Full Text] [Related]
9. Presence and severity of coronary artery disease and changes in B-type natriuretic peptide levels in patients with a normal systolic function.
Kim BS; Lee HJ; Shin HS; Yoon JH; Lee HY; Kim BJ; Sung KC; Kang JH; Lee MH; Park JR
Transl Res; 2006 Oct; 148(4):188-95. PubMed ID: 17002921
[TBL] [Abstract][Full Text] [Related]
10. Inflammatory pathways in patients with heart failure and preserved ejection fraction.
Niethammer M; Sieber M; von Haehling S; Anker SD; Munzel T; Horstick G; Genth-Zotz S
Int J Cardiol; 2008 Sep; 129(1):111-7. PubMed ID: 17658631
[TBL] [Abstract][Full Text] [Related]
11. Serial changes in adiponectin and BNP in ACS patients: paradoxical associations with each other and with prognosis.
Ang DS; Welsh P; Watt P; Nelson SM; Struthers A; Sattar N
Clin Sci (Lond); 2009 Jun; 117(1):41-8. PubMed ID: 19175359
[TBL] [Abstract][Full Text] [Related]
12. Adiponectin is released from the heart in patients with heart failure.
Takano H; Obata JE; Kodama Y; Kitta Y; Nakamura T; Mende A; Kawabata K; Saito Y; Fujioka D; Kobayashi T; Yano T; Sano K; Kugiyama K
Int J Cardiol; 2009 Feb; 132(2):221-6. PubMed ID: 18192035
[TBL] [Abstract][Full Text] [Related]
13. [Evaluation of serum adiponectin levels in patients with heart failure and relationship with functional capacity].
Oztürk M; Dursunoğlu D; Göksoy H; Rota S; Gür S
Turk Kardiyol Dern Ars; 2009 Sep; 37(6):384-90. PubMed ID: 20019451
[TBL] [Abstract][Full Text] [Related]
14. Cross-talk between the heart and adipose tissue in cachectic heart failure patients with respect to alterations in body composition: a prospective study.
Christensen HM; Kistorp C; Schou M; Keller N; Zerahn B; Frystyk J; Flyvbjerg A; Faber J
Metabolism; 2014 Jan; 63(1):141-9. PubMed ID: 24140097
[TBL] [Abstract][Full Text] [Related]
15. Serum adipokine zinc α2-glycoprotein and lipolysis in cachectic and noncachectic heart failure patients: relationship with neurohormonal and inflammatory biomarkers.
Tedeschi S; Pilotti E; Parenti E; Vicini V; Coghi P; Montanari A; Regolisti G; Fiaccadori E; Cabassi A
Metabolism; 2012 Jan; 61(1):37-42. PubMed ID: 21696792
[TBL] [Abstract][Full Text] [Related]
16. Plasma adiponectin in heart failure with and without cachexia: catabolic signal linking catabolism, symptomatic status, and prognosis.
Szabó T; Scherbakov N; Sandek A; Kung T; von Haehling S; Lainscak M; Jankowska EA; Rudovich N; Anker SD; Frystyk J; Flyvbjerg A; Pfeiffer AF; Doehner W
Nutr Metab Cardiovasc Dis; 2014 Jan; 24(1):50-6. PubMed ID: 23791298
[TBL] [Abstract][Full Text] [Related]
17. Adipokines in patients with cancer anorexia and cachexia.
Smiechowska J; Utech A; Taffet G; Hayes T; Marcelli M; Garcia JM
J Investig Med; 2010 Mar; 58(3):554-9. PubMed ID: 20215915
[TBL] [Abstract][Full Text] [Related]
18. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
[TBL] [Abstract][Full Text] [Related]
19. Physical activity is associated with risk factors for chronic disease across adult women's life cycle.
Woolf K; Reese CE; Mason MP; Beaird LC; Tudor-Locke C; Vaughan LA
J Am Diet Assoc; 2008 Jun; 108(6):948-59. PubMed ID: 18502225
[TBL] [Abstract][Full Text] [Related]
20. Pomegranate seed oil consumption during a period of high-fat feeding reduces weight gain and reduces type 2 diabetes risk in CD-1 mice.
McFarlin BK; Strohacker KA; Kueht ML
Br J Nutr; 2009 Jul; 102(1):54-9. PubMed ID: 19079947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
